Eli Lilly News — every source, one live feed
Track Eli Lilly news in real time — S&P 500 — pharma and GLP-1 drugs, LLY. fllwup^ collects the latest Eli Lilly headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest Eli Lilly headlines
- Lilly signs $5.9B deal with Stipple to unlock oncology targets — Fierce Biotech
- Is Lilly Stock's Winning Streak Skill Or Luck? — Yahoo Finance
- Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? — The Motley Fool
- Eli Lilly to Buy Calytrix Bio for Up to $1.5 Billion — WSJ
- Breakingviews - COMMENTARY: Eli Lilly’s $1.4 trln valuation is heavy with hope — Reuters
- Rhythm Pharmaceuticals gains on report Eli Lilly made $150/share offer with CVR (RYTM:NASDAQ) — Seeking Alpha
- Third-Party Vendor Linked to Eli Lilly Is Hit by Data Breach — Barron's
- A $1.5 Billion Reason Why Eli Lilly Stock Is in Focus — Barchart.com
- Final Trades: Berkshire Hathaway, Cisco and Eli Lilly — CNBC
- Eli Lilly (LLY) Enters Cancer Licensing Deal Worth $5.9 Billion — TipRanks
Follow Eli Lilly live on fllwup^ · Follow in any RSS reader — or browse all topics.
More S&P 500 — Healthcare: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.